
CohBar Investor Relations Material
Latest events

M&A Announcement
CohBar
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CohBar Inc
Access all reports
CohBar Inc. is a clinical-stage biotechnology company focused on developing therapeutics based on peptides derived from mitochondrial DNA. The company’s research centers on leveraging its proprietary mitochondrial peptide technology platform to address chronic and age-related diseases. CohBar’s pipeline targets conditions such as metabolic disorders, fibrotic diseases, cancer, and neurodegenerative diseases. The company is headquartered in Menlo Park, California, and its shares are listed on the NASDAQ Stock Exchange.
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
CWBR
Country
🇺🇸 United States